Stahl's Deprescriber's Guide by Strawn, Jeffrey R.; Stahl, Stephen M.;

GET 20% OFF
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.

Publisher's listprice GBP 59.99
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

28 660 Ft (27 295 Ft + 5% VAT)
Discount 20% (cc. 5 732 Ft off)
Discounted price 22 928 Ft (21 836 Ft + 5% VAT)

28 660 Ft

Availability

Not yet published.

Product details:

Publisher Cambridge University Press
Date of Publication 31 January 2026

ISBN 9781009642200
Binding Paperback
No. of pages512 pages
Language English

Short description:

Combines evidence-based data with clinically informed advice to support everyone who is deprescribing psychotropic medications.

Long description:

For decades, psychiatry has focused on initiating treatment-which medication to prescribe, in what dose, and for how long. But what happens when treatment needs to stop? How a medication is stopped is just as important as how it is started, and abrupt discontinuation can lead to unnecessary suffering, relapse, and often preventable withdrawal symptoms. Based on the principles of the bestselling Stahl's Prescriber's Guide, this essential resource provides user-friendly guidance on deprescribing or switching psychotropic medications safely and effectively. 64 medications are presented in a consistent format to facilitate rapid access to deprescribing information. Divided into color coded sections, the book allows the reader to identify key details about when and why to deprescribe, the risks and mechanisms of withdrawal, tapering protocols, cross-titration strategies, and how to distinguish withdrawal symptoms from relapse. Evidence-based recommendations and expert clinical insights make this a must-have manual for all psychiatric prescribers.

'Deprescribing medications is a necessary skill for all clinical psychopharmacologists, and is not a trivial task. Drs. Strawn and Stahl impart their collective wisdom as they meld their own experiences with what the medical literature informs us, offering advice for implementing winning strategies. Sagely eliminating medications that interfere with others is essential to the practice of optimal, and personalized, care. The key concept is that gradual dose reduction is often required to avoid 'rebound effects' but there are others that can be safely stopped abruptly - the wise practitioner will know which is which. Organized alphabetically, together with an index by drug class, the book is user friendly and thus easy to consult. Profusely illustrated with the award-winning figures that have made Stahl's series of books from Cambridge University Press famous, this book belongs on the shelves (and e-readers) of all clinicians involved in the care of people receiving psychotropic medications.' Leslie Citrome, MD, MPH, Clinical Professor of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, New York; Adjunct Professor of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, Illinois

Introduction; 1. Alprazolam; 2. Amitriptyline; 3. Amphetamine salts (d,l); 4. Aripiprazole; 5. Atomoxetine; 6. Benztropine; 7. Brexpiprazole; 8. Bupropion; 9. Buspirone; 10. Cariprazine; 11. Carbamazepine; 12. Chlorpromazine; 13. Citalopram; 14. Clomipramine; 15. Clonazepam; 16. Clonidine; 17. Clozapine; 18. Daridorexant; 19. Desipramine; 20. Desvenlafaxine; 21. Diazepam; 22. Diphenhydramine; 23. Divalproex/valproate; 24. Doxylamine; 25. Donepezil; 26. Duloxetine; 27. Escitalopram; 28. Eszopiclone; 29. Fluoxetine; 30. Fluvoxamine; 31. Gabapentin; 32. Galantamine; 33. Guanfacine; 34. Hydroxyzine; 35. Imipramine; 36. Lamotrigine; 37. Lemborexant; 38. Lisdexamfetamine; 39. Lithium; 40. Lorazepam; 41. Lumateperone; 42. Lurasidone; 43. Methylphenidate; 44. Mirtazapine; 45. Nortriptyline; 46. Olanzapine; 47. Paroxetine; 48. Pimavanserin; 49. Prazosin; 50. Pregabalin; 51. Propranolol; 52. Quetiapine; 53. Risperidone; 54. Rivastigmine; 55. Sertraline; 56. Suvorexant; 57. Trihexyphenidyl; 58. Venlafaxine; 59. Vilazodone; 60. Viloxazine; 61. Vortioxetine; 62. Ziprasidone; 63. Zaleplon; 64. Zolpidem.